Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 19

1.

Next Viable Routes to Targeting Pancreatic Cancer Stemness: Learning from Clinical Setbacks.

Tsai KK, Chan TS, Shaked Y.

J Clin Med. 2019 May 17;8(5). pii: E702. doi: 10.3390/jcm8050702. Review.

2.

Correction: ASPM promotes prostate cancer stemness and progression by augmenting Wnt-Dvl-3-β-catenin signaling.

Pai VC, Hsu CC, Chan TS, Liao WY, Chuu CP, Chen WY, Li CR, Lin CY, Huang SP, Chen LT, Tsai KK.

Oncogene. 2019 Feb;38(8):1354. doi: 10.1038/s41388-018-0561-0.

PMID:
30390070
3.

ASPM promotes prostate cancer stemness and progression by augmenting Wnt-Dvl-3-β-catenin signaling.

Pai VC, Hsu CC, Chan TS, Liao WY, Chuu CP, Chen WY, Li CR, Lin CY, Huang SP, Chen LT, Tsai KK.

Oncogene. 2019 Feb;38(8):1340-1353. doi: 10.1038/s41388-018-0497-4. Epub 2018 Sep 28. Erratum in: Oncogene. 2018 Nov 2;:.

PMID:
30266990
4.

Stress stimuli induce cancer-stemness gene expression via Sp1 activation leading to therapeutic resistance in glioblastoma.

Chang KY, Huang CT, Hsu TI, Hsu CC, Liu JJ, Chuang CK, Hung JJ, Chang WC, Tsai KK, Chuang JY.

Biochem Biophys Res Commun. 2017 Nov 4;493(1):14-19. doi: 10.1016/j.bbrc.2017.09.095. Epub 2017 Sep 19.

PMID:
28939040
5.

Metronomic chemotherapy prevents therapy-induced stromal activation and induction of tumor-initiating cells.

Chan TS, Hsu CC, Pai VC, Liao WY, Huang SS, Tan KT, Yen CJ, Hsu SC, Chen WY, Shan YS, Li CR, Lee MT, Jiang KY, Chu JM, Lien GS, Weaver VM, Tsai KK.

J Exp Med. 2016 Dec 12;213(13):2967-2988. Epub 2016 Nov 23.

6.

Targeting chemotherapy-induced PTX3 in tumor stroma to prevent the progression of drug-resistant cancers.

Chi JY, Hsiao YW, Li CF, Lo YC, Lin ZY, Hong JY, Liu YM, Han X, Wang SM, Chen BK, Tsai KK, Wang JM.

Oncotarget. 2015 Sep 15;6(27):23987-4001.

7.

Cancer/stroma interplay via cyclooxygenase-2 and indoleamine 2,3-dioxygenase promotes breast cancer progression.

Chen JY, Li CF, Kuo CC, Tsai KK, Hou MF, Hung WC.

Breast Cancer Res. 2014 Jul 25;16(4):410. doi: 10.1186/s13058-014-0410-1.

8.

A gene expression signature of epithelial tubulogenesis and a role for ASPM in pancreatic tumor progression.

Wang WY, Hsu CC, Wang TY, Li CR, Hou YC, Chu JM, Lee CT, Liu MS, Su JJ, Jian KY, Huang SS, Jiang SS, Shan YS, Lin PW, Shen YY, Lee MT, Chan TS, Chang CC, Chen CH, Chang IS, Lee YL, Chen LT, Tsai KK.

Gastroenterology. 2013 Nov;145(5):1110-20. doi: 10.1053/j.gastro.2013.07.040. Epub 2013 Jul 27.

PMID:
23896173
9.

Cholestane-3β, 5α, 6β-triol suppresses proliferation, migration, and invasion of human prostate cancer cells.

Lin CY, Huo C, Kuo LK, Hiipakka RA, Jones RB, Lin HP, Hung Y, Su LC, Tseng JC, Kuo YY, Wang YL, Fukui Y, Kao YH, Kokontis JM, Yeh CC, Chen L, Yang SD, Fu HH, Chen YW, Tsai KK, Chang JY, Chuu CP.

PLoS One. 2013 Jun 13;8(6):e65734. doi: 10.1371/journal.pone.0065734. Print 2013.

10.

The Skp2-SCF E3 Ligase Regulates Akt Ubiquitination, Glycolysis, Herceptin Sensitivity, and Tumorigenesis.

Chan CH, Li CF, Yang WL, Gao Y, Lee SW, Feng Z, Huang HY, Tsai KKC, Flores LG, Shao Y, Hazle JD, Yu D, Wei W, Sarbassov D, Hung MC, Nakayama KI, Lin HK.

Cell. 2012 Nov 9;151(4):913-914. doi: 10.1016/j.cell.2012.10.025. Epub 2012 Nov 8. No abstract available.

11.

Krüppel-like factor 10 expression as a prognostic indicator for pancreatic adenocarcinoma.

Chang VH, Chu PY, Peng SL, Mao TL, Shan YS, Hsu CF, Lin CY, Tsai KK, Yu WC, Ch'ang HJ.

Am J Pathol. 2012 Aug;181(2):423-30. doi: 10.1016/j.ajpath.2012.04.025. Epub 2012 Jun 9.

PMID:
22688058
12.

The Skp2-SCF E3 ligase regulates Akt ubiquitination, glycolysis, herceptin sensitivity, and tumorigenesis.

Chan CH, Li CF, Yang WL, Gao Y, Lee SW, Feng Z, Huang HY, Tsai KK, Flores LG, Shao Y, Hazle JD, Yu D, Wei W, Sarbassov D, Hung MC, Nakayama KI, Lin HK.

Cell. 2012 May 25;149(5):1098-111. doi: 10.1016/j.cell.2012.02.065. Erratum in: Cell. 2012 Nov 9;151(4):913-4. Cell. 2012 Nov 9;151(4):913-914.

13.

HOXA9 regulates BRCA1 expression to modulate human breast tumor phenotype.

Gilbert PM, Mouw JK, Unger MA, Lakins JN, Gbegnon MK, Clemmer VB, Benezra M, Licht JD, Boudreau NJ, Tsai KK, Welm AL, Feldman MD, Weber BL, Weaver VM.

J Clin Invest. 2010 May;120(5):1535-50. doi: 10.1172/JCI39534. Epub 2010 Apr 12.

14.

Low-dose radiation-induced senescent stromal fibroblasts render nearby breast cancer cells radioresistant.

Tsai KK, Stuart J, Chuang YY, Little JB, Yuan ZM.

Radiat Res. 2009 Sep;172(3):306-13. doi: 10.1667/RR1764.1.

15.

c-Abl regulates early growth response protein (EGR1) in response to oxidative stress.

Stuart JR, Kawai H, Tsai KK, Chuang EY, Yuan ZM.

Oncogene. 2005 Dec 8;24(55):8085-92.

PMID:
16091742
16.

Cellular mechanisms for low-dose ionizing radiation-induced perturbation of the breast tissue microenvironment.

Tsai KK, Chuang EY, Little JB, Yuan ZM.

Cancer Res. 2005 Aug 1;65(15):6734-44.

17.

Leukocyte mitochondrial alterations after cardiac surgery involving cardiopulmonary bypass: clinical correlations.

Kong CW, Huang CH, Hsu TG, Tsai KK, Hsu CF, Huang MC, Chen LC.

Shock. 2004 Apr;21(4):315-9.

PMID:
15179131
18.

DNA damage-induced MDMX degradation is mediated by MDM2.

Kawai H, Wiederschain D, Kitao H, Stuart J, Tsai KK, Yuan ZM.

J Biol Chem. 2003 Nov 14;278(46):45946-53. Epub 2003 Sep 8.

19.

c-Abl stabilizes p73 by a phosphorylation-augmented interaction.

Tsai KK, Yuan ZM.

Cancer Res. 2003 Jun 15;63(12):3418-24.

Supplemental Content

Loading ...
Support Center